The Journal

We read the fine print so you don't have to.

Honest, evidence-first reviews, buyer's guides, and comparisons for peptide telehealth providers and the compounds they work with. No hype, no gray-market vials.

32 guides · by The Peptide Samples Desk

Browse by format

Explore by topic

Popular tags

Comparison

Semaglutide vs. Tirzepatide

A neutral comparison of two FDA-approved prescription GLP-1 medications — what each is, their brand names, and how access differs across telehealth. Not a claim about results.

Read the guide →6 min read

Comparison

Peptides vs. TRT

A neutral comparison of two distinct telehealth categories — peptide therapy and testosterone replacement — on what each is, prescription status, and where each is offered.

Read the guide →6 min read

Comparison

Sermorelin vs. HGH

A neutral comparison of a prescription GH-secretagogue peptide and synthetic human growth hormone — focused on what each is, their very different legal status, and how access differs.

Read the guide →6 min read

Comparison

BPC-157 vs. TB-500

A neutral comparison of two recovery-category peptides — their regulatory status and how access differs across telehealth providers. Not a claim about what either does.

Read the guide →6 min read

Comparison

Sermorelin vs. Ipamorelin

A neutral comparison of two GH-secretagogue peptides — how they're categorized, their prescription status, and how access differs across telehealth providers.

Read the guide →6 min read

Explainer

How Peptide Telehealth Works

An educational, step-by-step look at the legitimate telehealth path for peptide care — the intake, labs, the licensed-provider consult, the prescription reality, and monitoring.

Read the guide →9 min read

Explainer

Research Peptides vs. Clinician-Prescribed Care

A direct, honest comparison of gray-market 'research only / not for human consumption' peptides and clinician-prescribed care — and why the difference matters more than the price.

Read the guide →8 min read

Explainer

Are Peptides Safe?

A neutral, honest explainer on how to think about peptide safety — why the answer depends on the compound, the source, and clinician oversight, not on marketing.

Read the guide →7 min read